pandemic influenza vaccine (OPKO Health)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namepandemic influenza vaccine (OPKO Health)

Drug Alias Namehemagglutinin modulator (OPKO Health)pandemic influenza vaccine (Academia Sinica)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators

TargetsInfluenza virus hemagglutinin glycoproteins

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesTaiwan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAcademia Sinica

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAcademia Sinica Opko Health Inc

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A